The field of cancer immunology has witnessed dramatic progress with the advent of immunotherapies targeting the tumor immune microenvironment (TIME).

Cellarity, a clinical-stage biotechnology company developing Cell State-Correcting therapies through integrated multi-omics and AI modeling, today provided a 2026 corporate outlook and update on key ...

Illumina, whose EMEA head office is at Granta Park in Cambridge, has released Illumina Connected Multiomics, a powerful cloud ...

Researchers developed two computational tools to decode how cells communicate in tissues. sCCIgen creates realistic virtual ...

In a paper published in the journal Nature Neuroscience, researchers have mapped how stress events during pregnancy can ...

Illumina, Inc. (NASDAQ: ILMN) today announced the release of Illumina Connected Multiomics, a powerful cloud-based research ...

The maternal microbiome and immune system have both independent and synergistic effects on fetal brain health - changes in the mother’s immune system have been linked to an increased risk of ...

The pelvis is often called the keystone of upright movement. It helps explain how human ancestors left life on all fours ...

Cancer is the second leading cause of death worldwide. Since age is one of the risk factors for the development of cancer, ...